3 documents

Medtronic will acquire Osteotech for $6.50 per share in cash, or about $123 million. The price is a 65% premium to Osteotech's close of $3.94 on August 16. Medtronic said the acquisition will complement its...

Medtronic Inc. (NYSE:MDT) will acquire Osteotech Inc. (NASDAQ:OSTE) for $6.50 per share in cash, or about $123 million. The price is a 65% premium to Osteotech's close of $3.94 on Monday. Medtronic said the acquisition...

China's State Food and Drug Administration (SFDA) approved Biocomposites' geneX as a bone graft substitute. The company said it would begin marketing the fully resorbable synthetic biomaterial with a negative surface charge in China immediately....